434 related articles for article (PubMed ID: 30720176)
1. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
[TBL] [Abstract][Full Text] [Related]
2. MiRNA-199 inhibits malignant progression of lung cancer through mediating RGS17.
Su WZ; Ren LF
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3390-3400. PubMed ID: 31081094
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
[TBL] [Abstract][Full Text] [Related]
5. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
Yang J; Du YM; Li B
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HOTAIR promotes colon cancer development by down-regulating miRNA-34a.
Peng CL; Zhao XJ; Wei CC; Wu JW
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5752-5761. PubMed ID: 31298326
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140.
Li Y; Xu J; Guo YN; Yang BB
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3401-3409. PubMed ID: 31081112
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of LncRNA ROR promoting prostate cancer by regulating Akt.
Zhai XQ; Meng FM; Hu SF; Sun P; Xu W
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1969-1977. PubMed ID: 30915739
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MSTO2P promotes proliferation and autophagy of lung cancer cells by up-regulating EZH2 expression.
Wang LJ; Sun GZ; Chen YF
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3375-3382. PubMed ID: 31081092
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p.
Ma XR; Xu YL; Qian J; Wang Y
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1536-1544. PubMed ID: 30840276
[TBL] [Abstract][Full Text] [Related]
16. LINC00324 exerts tumor-promoting functions in lung adenocarcinoma via targeting miR-615-5p/AKT1 axis.
Pan ZH; Guo XQ; Shan J; Luo SX
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8333-8342. PubMed ID: 30556874
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
[TBL] [Abstract][Full Text] [Related]
18. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p.
Chen AY; Zhang K; Liu GQ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772
[TBL] [Abstract][Full Text] [Related]
19. LINC01551 promotes metastasis of nasopharyngeal carcinoma through targeting microRNA-132-5p.
Xue MY; Cao HX
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3724-3733. PubMed ID: 32329849
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma.
Zhang L; Zhou XF; Pan GF; Zhao JP
Biomed Pharmacother; 2014 May; 68(4):401-7. PubMed ID: 24721325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]